Randomised Phase II Trial of Trofosfamide vs. Doxorubicin in Elderly Patients With Untreated Metastatic Soft-Tissue Sarcoma

European Journal of Cancer - United Kingdom
doi 10.1016/j.ejca.2019.10.016
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Pazopanib for Metastatic Soft-Tissue Sarcoma (PALETTE): A Randomised, Double-Blind, Placebo-Controlled Phase 3 Trial

The Lancet
Medicine
2012English

A Randomised Phase II Trial of Selumetinib vs Selumetinib Plus Temsirolimus for Soft-Tissue Sarcomas

British Journal of Cancer
Cancer ResearchOncology
2015English

Worse Survival in Elderly Patients With Extremity Soft-Tissue Sarcoma

Annals of Surgical Oncology
OncologySurgery
2016English

Very Long‐term Survivors Among Patients With Metastatic Soft Tissue Sarcoma

Cancer Medicine
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2019English

Erratum To: New Drug Developments for Patients With Metastatic Soft Tissue Sarcoma

Current Oncology Reports
Oncology
2012English

Olaratumab and Doxorubicin for the Treatment of Metastatic Soft Tissue Sarcoma: A Retrospective Case Series

Precision and Future Medicine
2019English

Prognostic Value of Monocyte and Neutrophils to Lymphocytes Ratio in Patients With Metastatic Soft Tissue Sarcoma

Oncotarget
Oncology
2015English

Trabectedin in the Treatment of Patients With Soft Tissue Sarcoma

Nowotwory
Cancer ResearchOncology
2018English

Phase II Trial of 17-Allylamino-17-Demethoxygeldanamycin in Patients With Metastatic Melanoma

Clinical Cancer Research
Cancer ResearchOncology
2008English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy